CMM Symposium: Scientific Program

October 10-11, 2017 | 315 Riverbend Road | Athens, GA 30602


11:30 am

12:50 pm
Welcome and Opening Comments
David Lee, Professor, Vice President for Research, University of Georgia, Athens, GA

12:55 pm
Introduction to Keynote Speaker
Stephen Dalton, Professor and Director of Center for Molecular Medicine, University of Georgia, Athens, GA

1:00 – 1:35 pm
Turning on Fetal Hemoglobin for Therapy: GWAS, gene editing, and new approaches
Stuart Orkin, David G. Nathan Distinguished Professor of Pediatrics, Investigator, Howard Hughes Medical Institute, Harvard Medical School, Boston, MA                         

Session 1

Chair – Tianming Wu

1:40 – 2:10 pm
Humans iPSCs for Precision Cardiovascular Medicine
Joseph Wu
, Professor and Director, Stanford Cardiovascular Institute, Stanford University, Stanford, CA

2:15 – 2:45 pm
Stem cell-based kidney regeneration and disease modeling

Zhongwei Li, Assistant Professor of Medicine and Stem Cell Biology and Regenerative Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA

2:50 – 3:20 pm
Using omics and big data to manage health and disease
Michael Snyder, Professor and Chair, Genetics,  Stanford University, Stanford, CA

3:25 – 4:00 pm

Session 2

Chair – Sally Boyd

4:00 – 4:30 pm
Epigenetic reprogramming in stem cells and development
Amander Clark, Professor, Department of Molecular, Cell & Developmental Biology, University of California, Los Angeles, CA

4:35 – 5:05 pm
Glycan Recognition in Innate and Adaptive Immunity
Richard Cummings, Professor and Director, National Center for Functional Glycomics, Harvard Medical School, Boston, MA

5:10 – 5:40 pm
Lysosomal Degradation of Heparan Sulfate
Jeff Esko, Distinguished Professor and Co-Director, Glycobiology Research and Training Center, University of California, San Diego, CA

5:45 – 6:30 pm

Wednesday, October 11

8:00 am
Continental Breakfast and Registration

Session 3

Chair – Dustin Middleton

9:00 – 9:30 am
Using iPSCs to discover drug treatments for inborn errors in hepatic metabolism
Stephen Duncan
, Professor and Chair, Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC

9:35 – 10:05 am
The Color of Fat: Brown, Beige, and White
Shingo Kajimura, Associate Professor, University of California, San Francisco, CA

10:05 – 10:20 am

Session 4

Chair – Yang Liu

10:25 – 10:55 am
Molecular regulation of muscle stem cell asymmetric division
Michael Rudnicki
, Senior Scientist, Regenerative Medicine Program, Ottawa Hospital Research Institute

11:00 – 11:30 am
Mechanistic Insights into O-Glycosylation-Deficient Muscular Dystrophy
Kevin Campbell, Professor, University of Iowa, Iowa City, IA

11:35 – 12:05 pm
Stem cells in the adult human retinal pigment epithelium – plasticity and promise for retinal regeneration
Sally Temple, Scientific Director, Neural Stem Cell Institute, Rensselaer, NY

12:10 – 1:30 pm

Session 5

Chair – Liang Zhang

1:30 – 2:00 pm
Pancreatic long non-coding RNAs regulate islet function
Lori Sussel, Director, Research Director, Barbara Davis Center for Diabetes, University of Colorado, Denver, CO

2:05 – 2:35 pm
Generating human pluripotent stem cell-derived tissues as models for diabetes and digestive diseases
Jim Wells, Professor and Director of Basic Research, Division of Endocrinology, Cincinnati Children’s Hospital, Cincinnati, OH

2:40 – 3:10 pm
T cell Memory and Exhaustion
Rafi Ahmed, Director, Emory Vaccine Center, Emory University, Atlanta, GA

3:15 pm
Closing Remarks

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Piedmont Athens Regional and UGA Center for Molecular Medicine. Piedmont Athens Regional is accredited by the Medical Association of Georgia to provide continuing medical education for physicians.

Piedmont Athens Regional designates this live activity for a maximum of 8 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.